Clinical trial
Restenosis Inhibition by Short-Term Exposure to Lipophilic Anti-proliferative Drugs Delivered by Angiographic Contrast Media
NCT01140204 is registered in ClinicalTrials.gov with University Hospital, Saarland as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Restenosis Inhibition by Short-Term Exposure to Lipophilic Anti-proliferative Drugs Delivered by Angiographic Contrast Media
- Lead sponsor
- University Hospital, Saarland
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- March 31, 2003
- Completion date
- June 30, 2004
- Enrollment
- 32 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.